Doctor profile · Federal record
Dr. Michael Hall, M.D.
Medical Oncology Physician (CMS: Hematopoietic Cell Transplantation and Cellular Therapy) · Philadelphia, PA
- NPI 1811941644
- Accepts Medicare
- MIPS 72.5 / 100 · 2023
- 27 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
333 Cottman Ave, Fox Chase Cancer Center
Philadelphia, PA 191112434
(215) 728-6900
fax (215) 728-3639 - Mailing address
-
2450 W Hunting Park Ave
Philadelphia, PA 191291302
Credentials & registration
- NPI registered
- May 2006 — 20 yrs on file
- Profile last updated
- April 9, 2018
- Year of graduation
- 1999 — 27 yrs since
- Specialty taxonomy
- 207RX0202X — NUCC code
- State license (1)
- Pennsylvania #MD435434
- Medicaid
- PA #1022211930001
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1811941644. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
290
Distinct HCPCS
6
Medicare allowed
$32,396
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 113 | 70 | $96 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 102 | 50 | $144 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 34 | 34 | $69 | |
99202 |
New patient office or other outpatient visit, 15-29 minutes | 15 | 15 | $49 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 14 | 14 | $189 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 12 | 12 | $87 |
In context: peer comparison
Among 48 peers in this city , average services per provider: 121. This provider delivers 2.4× the peer median.Open Payments
Industry payments received
All-time total
$550
Transactions
10
Manufacturers
4
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $317.59 | |
| Regeneron Healthcare Solutions, Inc. | 3 | $171.72 | |
| Myriad Genetic Laboratories, Inc. | 1 | $44.78 | |
| Kerecis Limited | 1 | $16.00 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
70
Patients
27
Total drug cost
$111,420
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ondansetron Hcl | Generic | 33 | 14 | $248 |
| Prochlorperazine Maleate | Generic | 25 | 13 | $266 |
| Lonsurf (Trifluridine/Tipiracil Hcl) | Brand | 12 | 0 | $110,906 |
Hospital affiliations
Frequently asked questions
What is Dr. Michael Hall's medical specialty?
Dr. Michael Hall practices Medical Oncology Physician in Philadelphia, PA.
Where does Dr. Michael Hall practice?
Dr. Michael Hall practices at 333 Cottman Ave, Philadelphia, PA 191112434. Office phone: 2157286900.
What is Dr. Michael Hall's NPI?
Dr. Michael Hall's National Provider Identifier (NPI) is 1811941644, issued by NPPES.
Does Dr. Michael Hall accept Medicare assignment?
Yes. Dr. Michael Hall accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Michael Hall commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Established patient office or other outpatient visit (HCPCS 99215); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.